HOME >> MEDICINE >> NEWS
Karolinska Institutet prize for innovations in medical pedagogics

Professor Ronald M. Harden, Britain, has been awarded the 2006 Karolinska Institutet prize for research into the field of medical pedagogics. This is the second time that the 50,000 Euro prize has been awarded, in an effort to elevate the long term quality of medical education in Sweden and abroad.

Professor Ronald M. Harden has been awarded the prize in recognition of his innovations in the field of medical teaching. His ideas and researches into examinations, the assessment of medical competence and course design has had a profound impact on medical education the world over.

"What's interesting about Professor Harden's pedagogical methods is his highly effective way of combining theory and practice," says Vivi-Anne Sundqvist, Dean of Higher Education at Karolinska Institutet. "It is very much in harmony with the Swedish way of looking at teaching methodology in the medical field, which involves a great deal of clinical training."

Professor Harden studied medicine at Glasgow and worked as an endocrinologist before moving full time into education. He is currently the Director of Education at the International Virtual Medical School (IVIMEDS) in Scotland. He is also the General Secretary of the Association for Medical Education in Europe (AMEE).

The Karolinska Institutet prize for research into medical pedagogics was first awarded in 2004. The prize was set up and is financed by the Gunnar Hglund and Anna-Stina Malmborg foundation.

"We'll all be patients sooner or later," says Professor Emeritus Gunnar Hglund at Karolinska Institutet's Centre of Education and Learning. "Medical education is fundamental to the competence of those who look after us. The idea of the prize is to draw attention to just how important medical training is, and to encourage, and honour, researchers who help to improve its quality."

The announcement of this year's prize winner was made at the AMEE conference in Genua at the week
'"/>

Contact: Katarina Sternudd
katarina.sternudd@ki.se
46-852-483-895
Karolinska Institutet
18-Sep-2006


Page: 1 2

Related medicine news :

1. Karolinska Institute and Harvard in a unique training initiative
2. Polish journalist scoops first prize in prestigious European award
3. MIT graduate student wins $30,000 Lemelson-MIT student prize for life-saving inventions
4. Top NIH prize goes to three pioneering Stanford scientists
5. UCI epilepsy researcher receives nations top neuroscience prize
6. Daniel Zheng wins SIAMs first prize at INTEL-ISEF
7. Penn Scientist receives first annual prize for scientific contributions to womens health
8. Karen Duff receives prestigious prize for Alzheimers research
9. New TB test scoops top prize at Medical Futures competition
10. MRI pioneer wins national physics prize
11. Cancer researcher Susan Horwitz wins Alpert prize for Taxol work

Post Your Comments:
(Date:5/22/2013)... Margate City, NJ (PRWEB) May 22, 2013 ... from solved. In some states, up to twenty-seven percent ... half of all bankruptcies of private citizens in the U.S. ... medical care also affects prescription drugs, meaning that many patients ... doctor, or even get them filled at all. That's ...
(Date:5/22/2013)... Beginning Aug. 22, teens are invited ... Spirit of Innovation Challenge . The annual program ... and open to students ages 13 - 18 from ... Challenge celebrates the life and entrepreneurial spirit of astronaut ... The program challenges teens to work in teams of ...
(Date:5/22/2013)... May 22, 2013 The 2013 release of ... is the largest change to hit the field of mental ... is will help prepare for the release with a Webinar ... been trained knowing no other diagnostic scheme besides the now ... manual will be released worldwide. In honor of this event, ...
(Date:5/22/2013)... May 22, 2013 Abadir Associates, a ... treatments for optimal results, is offering a new technique ... neck. The practice has successfully treated multiple patients ... “Basically, this approach is for women who want to ... dermatologist Dr. Michelle Abadir of Abadir Associates. ...
(Date:5/22/2013)... May 22 2013 - Research presented today shows ... in rats similar to those produced by drugs ... presented by addiction expert Francesco Leri, Associate Professor ... University of Guelph, suggest food addiction could explain, ... These results were presented at the 2013 ...
Breaking Medicine News(10 mins):Health News:Lyrica Discount Cards Now Available From MedicationDiscountCard.com 2Health News:Conrad Foundation Announces 2013-2014 Spirit of Innovation Challenge Launch Date 2Health News:What You Need to Know About DSM-5: The Asheville Jung Center is Hosting a Webinar Tonight on the New Material in DSM-5 2Health News:Westchester Dermatologist Abadir Associates Offers New Neck Lift Surgery Alternative 2Health News:Addiction to unhealthy foods could help explain the global obesity epidemic 2
(Date:5/22/2013)... 22, 2013   Upsher-Smith Laboratories, Inc. ... its global Phase III clinical trial for ... for the management of epilepsy in adults, ... is specifically engineered to provide convenient once-daily ... levels observed with currently available treatment options.  ...
(Date:5/22/2013)... 22, 2013  Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ... of the company at the following conferences. , ... date: Wednesday May 29, 2013 , Presentation time: 12:00 ... Conference , Presentation date: Wednesday June 5, 2013 ... A live webcast and 30-day archive of these ...
(Date:5/22/2013)... REHOVOT, Israel , May 22, 2013 ... a leading developer and provider of microRNA-based molecular diagnostics, ... President and Chief Executive Officer of Rosetta Genomics, will ... Conference taking place from June 3-6, 2013 in New ... Tuesday, June 4 th at 2:00 p.m. Eastern ...
Breaking Medicine Technology:Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3
Cached News: